非侵襲的換気療法を受けている慢性閉塞性肺疾患患者のアウトカムに対する補完療法の効果：システマティックレビュー

COPD patients receiving noninvasive ventilation (NIV) face many physiological and psychosocial problems. The impact of complementary therapies on NIV adherence and symptom management in COPD patients is not sufficiently addressed.

This systematic review was conducted to examine the effectiveness of complementary therapies used in COPD patients receiving NIV on clinical symptoms and health outcomes.

A systematic review was designed based on PRISMA-P (Preferred Reporting Items for Systematic review and Meta-Analysis Protocols) criteria. The literature search was conducted in the "PubMed, Cochrane, Scopus, Web of Science, Google Scholar" databases. Studies were selected by determining inclusion and exclusion criteria according to the PICOT method. Studies were evaluated using the Joanna Briggs Institute (JBI) critical assessment lists.

Five randomized controlled trials were included in the systematic review, which included a total of 338 COPD patients receiving NIV. Most studies have found that complementary therapies significantly reduce anxiety and dyspnea levels. Significant improvements were observed in physical capacity and quality of life.

Complementary therapies may offer potential benefits for clinical symptoms and health outcomes in patients receiving NIV, including anxiety, dyspnea, physical capacity and quality of life. However, the findings are limited by substantial heterogeneity and methodological shortcomings among the included studies. Well-designed, controlled clinical trials are needed to provide more definitive evidence regarding the effects of complementary therapies in this population.

The current evidence remains insufficient to support the routine incorporation of complementary therapies into critical care practice for patients with COPD receiving NIV. Further high-quality studies are required to guide nursing practice and support the integration of complementary therapies into holistic care.